Johnson & Johnson (NYSE: JNJ) announced it has entered into a definitive agreement to acquire Firefly Bio, Inc. for $1 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE